docetaxelatezolizumabtasquinimodS100A8/A9NSCLC
… as well as pathway analysis using MsigDB. Patient outcomes for docetaxel and atezolizumab were assessed in OAK and POPLAR clinical trial…
1articles mentioning drugs
4drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: tasquinimod ×
tasquinimod
This drug is selected. Its supporting articles are shown below.